http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104357402-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42 |
| filingDate | 2014-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104357402-B |
| titleOfInvention | Monoclonal antibody with prevention and treatment gosling plague effect |
| abstract | It is related to two plants of anti gosling plague virus monoclonal antibody hybridoma cell strains that can be secreted with prevention and/or therapeutic action the invention discloses a kind of, cell line is immunized mouse using the Goose Parvovirus of purifying and is prepared, GPV Mab 6D8 and GPV Mab 4E7 are respectively designated as, cyropreservation numbering is respectively CGMCC NO.9577 and CGMCC NO.9578.A kind of monoclonal antibody with prevention and treatment gosling plague effect, the monoclonal antibody is secreted by deposit number CGMCC NO.9577 and CGMCC NO.9578 hybridoma cell strain to be produced.The present invention can not only neutralize the infection of Goose Parvovirus in vitro using the monoclonal antibody prepared by two plants of hybridomas, can also prevent in zoopery and/or treat gosling plague. |
| priorityDate | 2014-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451186576 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61365 |
Total number of triples: 15.